XML 27 R39.htm IDEA: XBRL DOCUMENT v3.20.1
OPERATING SEGMENTS AND GEOGRAPHIC INFORMATION (Tables)
3 Months Ended
Mar. 31, 2020
OPERATING SEGMENTS  
Schedule of financial information for each of the entity's reportable segments, including the impact of the preceding changes on previously reported full year 2019 net sales and oeprating income

December 31, 2019

  

2019 Reported

  

  

Fixed

  

2019 Revised

Valued at 2019

  

Segment

  

Currency

  

Valued at 2020

(millions)

Management Rates

  

Change

  

Rate Change

  

Management Rates

Net Sales

  

  

Global Industrial

$5,569.9

$479.2

$(52.7)

$5,996.4

Global Institutional

5,235.5

(800.1)

(23.3)

4,412.1

Global Healthcare and Life Sciences

-

991.7

(12.7)

979.0

Upstream Energy

-

2,350.0

2.9

2,352.9

Global Energy

3,334.0

(3,334.0)

-

-

Other

907.5

313.2

(9.0)

1,211.7

Subtotal at fixed currency rates

15,046.9

-

(94.8)

14,952.1

Effect of foreign currency translation

(140.6)

-

94.8

(45.8)

Consolidated reported GAAP net sales

$14,906.3

$-

$-

$14,906.3

Operating Income

Global Industrial

$854.7

$133.4

$(7.5)

$980.6

Global Institutional

1,042.2

(93.4)

(1.5)

947.3

Global Healthcare and Life Sciences

-

136.7

(1.6)

135.1

Upstream Energy

-

188.2

(0.3)

187.9

Global Energy

379.1

(379.1)

-

-

Other

167.3

14.2

(0.9)

180.6

Corporate

(409.1)

-

1.2

(407.9)

Subtotal at fixed currency rates

2,034.2

-

(10.6)

2,023.6

Effect of foreign currency translation

(20.4)

-

10.6

(9.8)

Consolidated reported GAAP operating income

$2,013.8

$-

$-

$2,013.8

Schedule of financial information for each of the entity's reportable segments

First Quarter Ended 

March 31

(millions)

    

2020

2019

Net Sales

Global Industrial

 

$1,444.0

$1,397.4

Global Institutional

1,072.3

1,020.2

Global Healthcare and Life Sciences

246.2

227.0

Upstream Energy

562.7

581.7

Other

277.8

274.7

Subtotal at fixed currency rates

3,603.0

3,501.0

Effect of foreign currency translation

(21.6)

4.4

Consolidated reported GAAP net sales

 

$3,581.4

 

$3,505.4

Operating Income

Global Industrial

 

$226.9

$181.2

Global Institutional

183.5

176.2

Global Healthcare and Life Sciences

25.6

27.3

Upstream Energy

39.0

36.5

Other

25.3

28.9

Corporate

(100.2)

(83.4)

Subtotal at fixed currency rates

400.1

366.7

Effect of foreign currency translation

(2.9)

0.5

Consolidated reported GAAP operating income

 

$397.2

 

$367.2